visible-on: Access Campaign
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent
Tuberculosis: MSF responds to updated WHO guidelines for tuberculosis in children
MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib
